Medical/Pharmaceuticals

Alphamab Oncology Collaborated with ArriVent in relation to the Research, Development and Commercialization of ADC Products

SUZHOU, China, June 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Alphamab"), a wholly-owned subsidiary of the Company, entered into a research and collaboration agreement (the "Collaboration Agreement") with ArriVen...

2024-06-06 10:21 2114

STRENGTHENING PATIENT CARE AND SAFETY IN COMPLEX, HIGH-RISK PAEDIATRIC LIVER TRANSPLANT SURGERY

Innovative mixed reality technology enhances pre-surgical planning at NUH's specialised paediatric organ transplant centre inSingapore SINGAPORE, June 5, 2024 /PRNewswire/ --  For the last three decades, the transplant team at theNational University Hospital (NUH)'s Department of Paediatric Surg...

2024-06-05 22:00 2035

Pricing plan from Done aims to make diagnosis and treatment of ADHD more accessible and affordable

SAN FRANCISCO, June 5, 2024 /PRNewswire/ -- Healthcare can be a significant financial burden on many individuals and families, even with insurance. The costs associated with one of the more common health issues in the US, the diagnosis and treatment of adult ADHD, can spill over into many aspects...

2024-06-05 22:00 1991

RemeGen Showcases Research Results at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, Highlighting Its Prolific Innovation in Global Cancer Treatment

YANTAI, China, June 5, 2024 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, showcased its innovation in the field of global cancer treatment at the American Society of Clinical Oncology Annu...

2024-06-05 21:42 2436

Sunway Medical Centre retains Malaysia's top spot in Paediatrics, according to latest Newsweek rankings

The hospital is also ranked highly in the areas of Oncology, Neurology, Neurosurgery, Cardiology, and Cardiac Surgery. SUNWAY CITY, Malaysia, June 5, 2024 /PRNewswire/ -- Sunway Medical Centre (SMC), Sunway City, the flagship quaternary hospital under the Sunway Healthcare Group, retained its to...

2024-06-05 20:00 2509

Oricell Presented Long-term Follow-up Data of OriCAR-017 in RRMM at 2024 ASCO Annual Meeting, Highlighting the Sustained Efficacy of GPRC5D CAR-T Therapy

SHANGHAI and ROSELAND, N.J., June 5, 2024 /PRNewswire/ -- Oricell Therapeutics, a pioneering clinical-stage biopharmaceutical company, has presented the two-year long-term follow-up results of OriCAR-017, an open-label Phase I study evaluating GPRC5D-targeted CAR-T therapy in patients with relaps...

2024-06-05 19:59 2048

FDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for mCRPC

HEFEI, China, June 5, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has recently approved a Phase II/III clinical trial of KPG-121 in combination with Abiraterone for a first-line treatment of metastatic castration resistant prost...

2024-06-05 19:00 1701

Crisis24 Combines Elite Concierge Medical Practice and Personal Protection Services to Form new Crisis24 Private Strategic Group division

Delivers "head of state" experience in personal protection and elite supplemental medical concierge services to world's most influential people, disruptive brands,and prominent organizations.  BOCA RATON, Fla., June 5, 2024 /PRNewswire/ -- Crisis24, a GardaWorld company, and a global leader in i...

2024-06-05 19:00 1433

Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations

CASTRES, France, June 5, 2024 /PRNewswire/ -- Pierre Fabre Laboratories today announced the filing of an investigational new drug ("IND") application to the U.S. Food and Drug Administration ("FDA") to initiate a first-in-human (FIH) Phase I/II clinical trial with PFL-002/VERT-002 for solid tumor...

2024-06-05 15:15 1933

Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series

XI'AN, China, June 5, 2024 /PRNewswire/ -- In honor of World Environment Day on 5 June,Tianlong , an innovative R&D company specializing in molecular diagnostic products, demonstrates its dedication to environmental sustainability and cleanliness through the introduction o...

2024-06-05 14:13 2449

GC Genome Highlights Promising New Approach for Non-invasive Colorectal Cancer Detection at ASCO 2024

YONGIN, South Korea, June 5, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, presented new data from its AI-based liquid biopsy platform for non-invasive colorectal cancer (CRC) detection at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Conducted...

2024-06-05 14:00 1996

ASG Pioneers Development of novel inhaled drugs and Accelerates R&D Progress

TAIPEI, June 5, 2024 /PRNewswire/ – Asia Scientific Global (ASG), a leader in the research and development of novel inhaled drugs, has set up a laboratory in Taiwan, and plans to establish a second facility in Singapore later this year. This new lab will focus on developing 505(b)2 new dosage form...

2024-06-05 12:30 1643

Live from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3%

SUZHOU, China and ROCKVILLE, Md., June 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated clinical data of olvere...

2024-06-05 11:46 1446

Live from ASCO 2024 | Ascentage Pharma Releases Updated Data Showing Promising Efficacy and Safety of Lisaftoclax in Patients with WM

SUZHOU, China, and ROCKVILLE, Md., June 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated results from a global,...

2024-06-05 11:31 1369

Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line from 3P innovation

TORONTO, June 5, 2024 /PRNewswire/ -- Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a fully automated state-of-the-art high-speed aseptic powder filling line to expedite the ...

2024-06-05 10:00 1493

RestoringVision Awarded $4 Million Grant to Restore Sight to 2.5 Million People with Presbyopia in India and Nigeria

SAN FRANCISCO, June 4, 2024 /PRNewswire/ -- RestoringVision has been awarded a $4 million grant from Founders Pledge to address presbyopia at scale in India andNigeria. This investment will enable RestoringVision to implement three large-scale initiatives with its partners to provide reading glas...

2024-06-04 22:32 2102

Zymo Research Unveils PureRec DSN: The Most Selective Duplex-Specific Nuclease

IRVINE, Calif., June 4, 2024 /PRNewswire/ -- Zymo Research, a leader in biotechnological advancement has launched a new nuclease calledPureRec Duplex-Specific Nuclease (DSN) that selectively digests double stranded DNA (dsDNA). This new PureRec DSN promises unparalleled specificity in targeting ...

2024-06-04 21:00 1313

CARsgen Presents Updated Results on Satri-cel in Nature Medicine and at 2024 ASCO

SHANGHAI, June 4, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the final follow-up results of the investigator-initiated trial C...

2024-06-04 20:50 1673

Masdar City to Showcase Its Life Sciences Hub at BIO24 in San Diego

Masdar City to showcase why they are the leading destination for the life sciences sector at BIO24 ABU DHABI, UAE, June 4, 2024 /PRNewswire/ -- Highlighting its growing status as a leading destination for the life sciences sector, Masdar City,Abu Dhabi's flagship sustainable city in theUnited Ar...

2024-06-04 19:57 3506

FDA Clearance For Gastrointestinal Parasite Detection Kit

MELBOURNE, Australia, June 4, 2024 /PRNewswire/ -- Genetic Signatures Limited [ASX:GSS]("GSS" or the "Company"), a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Company'sEasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 aut...

2024-06-04 19:00 1384
1 ... 56575859606162 ... 610

Week's Top Stories